International Clinical Trial: A bioequivalence study of Niraparib 100 mg Tablets in Female Participants with Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer under Fasting Condition

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117002) titled 'A bioequivalence study of Niraparib 100 mg Tablets in Female Participants with Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer under Fasting Condition' on Sept. 3.

Study Type: BA/BE

Study Design: Other Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Open Label

Primary Sponsor: Pharmascience Inc.

Condition: Health Condition 1: C570- Malignant neoplasm of fallopian tube Health Condition 2: C56- Malignant neoplasm of ovary Health Condition 3: C482- Malignant neoplasm of peritoneum,uns...